Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nicotinic acetylcholine receptor subunit alpha-7 (α7 nAChR) is a homopentameric ligand-gated ion channel formed by five identical α7 subunits. It is highly permeable to calcium ions and plays critical roles in neuronal and non-neuronal signaling. It is implicated in cognitive disorders such as Alzheimer's disease and schizophrenia, and its modulation is considered promising for treatment strategies targeting these conditions. Other roles include neuroprotection, inflammation regulation, pain modulation, and cancer progression.
Agonist, antagonist, or positive allosteric modulator of α7 nAChR
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinic Acetylcholine Receptor Subunit Alpha-7.